Takinib | Takinib : Inhibitor of MAP3K7
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
MAP3K7
  • IC50:5.46 nM
  • Kd:200 nM
  • IC50:9.5 nM
  • EC50:2 µM
up to 5 µM

Selectivity

In Vitro Selectivity Assessment
IRAK4

Gene ID: Q9NWZ3

Organism: Homo sapiens

Family: TKL Ser/Thr protein kinase family

Potency: IC50 - 120 nM

Selectivity Assessment Description:
Screened at 10 µM against 140 kinases, Dundee Selectivity Profiling. Closest targets >90% of control ...

Potency
Cellular
In Vitro

MAP3K7

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1016/j.chembiol.2017.07.011

In Vivo Validations

Mouse
Dose: 50 mg/kg
Route of delivery: Intraperitoneal
Plasma half life: 0.2566 h

DOI Reference: 10.1016/j.chembiol.2017.07.011

Chemical Information

Molecular Formula C18H18N4O2
SMILEs CCCn1c(/N=C(\O)c2cccc(C(=N)O)c2)nc2ccccc21
InChI InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24)
Molecular weight 322.14 Da
AlogP 3.9659700000000013
HBond acceptors 6
HBond donors 3
Atoms 42

References

Expert Reviews


No SERP comments found for Takinib

Probe Takinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.

If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website